The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor

Junior, Claudio Antonio da Silva; Junior, Célio José de Castro; Pereira, Elizete Maria Rita; Binda, Nancy Scardua; Silva, Juliana Figueira da; Cordeiro, Marta do Nascimento; Diniz, Danuza Montijo; Santa-Cecília, Flávia Viana; Ferreira, Juliano; Gomez, Marcus Vinicius.
Pharmacol Rep, v. 72, p. 47-54, jan. 2020
Artículo en Inglés | SES-SP, SESSP-IBPROD, SES-SP | ID: bud-2925

Documentos relacionados

  1. The inhibitory effect of Pha1ß toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor
  2. The inhibitory effect of Phα1ß toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.
  3. An Anthranilate Derivative Inhibits Glutamate Release and Glutamate Excitotoxicity in Rats.
  4. m-Calpain is released from striatal synaptosomes.